ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

94. Rao SP, Oreopoulos DG. Unusual complications of a polyurethane PD catheter. Perit Dial Int 1997; 17:410?2.95. Riu S, Ruiz CG, Martinez-Vea A, Peralta C, Oliver JA. Spontaneous rupture of polyurethane peritonealcatheter. A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 1998; 13:1870?1.96. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidinegluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics2001; 107:1431?6.97. Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural cathetercolonization and infection: a meta-analysis. J Antimicrob Chemother 2006; 58:281?7.98. Levy I, Katz J, Solter E, et al. Chlorhexidine-impregnated dressing for prevention of colonization of centralvenous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J 2005; 24:676?9.99. Lorenzen AN, Itkin DJ. Surveillance of infection in home care. Am J Infect Control 1992; 20:326?9.100. White MC. Infections and infection risks in home care settings. Infect Control Hosp Epidemiol 1992;13:535?9.101. White MC, Ragland KE. Surveillance of intravenous catheter-related infections among home care clients.Am J Infect Control 1994; 22:231?5.102. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidinebathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. ArchIntern Med 2007; 167:2073?9.103. Munoz-Price LS, Hota B, Stemer A, Weinstein RA. Prevention of bloodstream infections by use of dailychlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30:1031?5.104. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Effectiveness of routine patient cleansing withchlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control HospEpidemiol 2009; 30:959?63.105. Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications ofperipherally inserted central venous catheters. J Vasc Interv Radiol 2002; 13:77?81.106. Brun-Buisson C, Doyon F, Sollet JP, Cochard JF, Cohen Y, Nitenberg G. Prevention of intravascularcatheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomizedcontrolled trial. Intensive Care Med 2004; 30:837?43.107. Ostendorf T, Meinhold A, Harter C, et al. Chlorhexidine and silver-sulfadiazine coated central venouscatheters in haematological patients?a double-blind, randomised, prospective, controlled trial. Support CareCancer 2005; 13:993?1000.108. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated withchlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.Ann Intern Med 2005; 143:570?80.109. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venouscatheters. Catheter Study Group. N Engl J Med 1999; 340:1?8.110. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for theprevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. TheTexas Medical Center Catheter Study Group. Ann Intern Med 1997; 127:267?74.111. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone central venous catheters impregnated withminocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: aprospective randomized clinical trial. J Clin Oncol 2004; 22:3163?71.54